Investor Relations

Zosano Pharma is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy, but altering their delivery profile using the Company’s proprietary transdermal delivery system. The Company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action.

NASDAQ: ZSAN
1.45
+ 0.05 (+3.57%)
Day High: 1.45
Day Low:  1.39
Volume:    641,464
4:00 PM ET on Jun 23, 2017

Delayed at least 20 minutes.